Skip Navigation

Find a Doctor

Find a Researcher


Michael Adam Gorin, M.D.

Photo of Dr. Michael Adam Gorin, M.D.
4.6 out of 5
138 Ratings
  • Director of the Prostate Cancer Precision Medicine Center of Excellence
  • Assistant Professor of Urology

Specializes in: Adults (18+ years)



Ablation, Active Surveillance of Prostate Cancer, Advanced Laparoscopy, Benign Prostatic Hyperplasia (BPH), Cryosurgery, Kidney biopsy , Kidney Cancer, Kidney Stones, Kidney Tumors, Laparoscopic Kidney Surgery, Lower Urinary Tract Obstruction, Minimally Invasive Surgery, Prostate Cancer, Prostate Disease, Robotic Prostatectomy, Robotic Surgery, Urology more

Request an Appointment

Insurance Information



Outside of Maryland

Request Appointment

International Patients

Request Appointment


The Johns Hopkins Hospital

Appointment Phone: 410-955-6100
600 N. Wolfe Street
Park 213
Baltimore, MD 21287 map
Phone: 410-502-7710 | Fax: 410-502-7711

Johns Hopkins Medicine - Green Spring Station

Appointment Phone: 410-955-6100
10803 Falls Road
Pavilion III, Suite 3300
Lutherville, MD 21093 map
Phone: 410-616-7600



  • Director of the Prostate Cancer Precision Medicine Center of Excellence
  • Director of Clinical Operations
  • Director of Urology Clinical Trials
  • Co-Director of the Prostate Cancer Multidisciplinary Clinic
  • Assistant Professor of Urology
  • Assistant Professor of Oncology
  • Assistant Professor of Pathology
  • Assistant Professor of Radiology and Radiological Science

Departments / Divisions



  • MD, University of Miami Miller School of Medicine (2011)


  • Johns Hopkins University School of Medicine / Urology (2017)

Board Certifications

  • Pending/Scheduled / Urology

Research & Publications

Selected Publications

View all on Pubmed

Gorin MA, Rowe SP, Patel HD, Vidal I, Mana-Ay M, Javadi MS, Solnes LB, Ross AE, Schaeffer EM, Bivalacqua TJ, Partin AW, Pienta KJ, Szabo Z, De Marzo AM, Pomper MG, Allaf ME. PSMA-targeted 18F-DCFPyL PET/CT in the preoperative staging of men with high-risk prostate cancer: results of a prospective phase II single-center study. J Urol 2017; in press

Gorin MA, Rowe SP, Denmeade SR. Clinical applications of molecular imaging in the management of prostate cancer. PET Clin 2017; 12: 185-192

Gorin MA, Rowe SP, Baras A, Solnes L, Ball MW, Pierorazio PM, Pavlovich CP, Epstein JI, Javadi MS, Allaf ME. Prospective evaluation of 99mTc-sestamibi SPECT/CT for the diagnosis of renal oncocytomas and hybrid oncocytic/chromophobe tumors. Eur Urol 2016; 69(3): 413-6

Gorin MA, Pomper MG, Pienta KJ, Rowe SP. Defining the clinical utility of PSMA-targeted PET imaging of prostate cancer. BJU Int 2017; 120(2): 160-161

Rowe SP, Javadi MS, Allaf ME, Gorin MA. Characterization of indeterminate renal masses with molecular imaging: how do we turn potential into reality? EJNMMI Res 2017; 7(1): 34

Activities & Honors


  • American Urological Association, 2011

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 


Is this you? Edit Profile
back to top button